Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
72
Views
9
CrossRef citations to date
0
Altmetric
Original Research

The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial

Yong-Hong Hu1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];2 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China, [email protected]
,
Jia-Wang Wei1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];2 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China, [email protected];3 Departments of Oncology, Ganzhou People’s Hospital, Ganzhou, Jiangxi, People’s Republic of China
,
Hui Chang1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];2 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China, [email protected]
,
Wei-Wei Xiao1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];2 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China, [email protected]
,
Jun-Zhong Lin1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];4 Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China
,
Mu-Yan Cai1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];5 Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China
,
Pei-Qiang Cai1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];6 Department of Medical Imaging and Interventional Radiology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China
,
Ling-Heng Kong1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];4 Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China
,
Gong Chen1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];4 Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China
,
Zhi-Zhong Pan1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];4 Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China
,
Zhi-Fan Zeng1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];2 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China, [email protected]
,
Pei-Rong Ding1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];4 Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China
&
Yuan-Hong Gao1 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China, [email protected];2 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China, [email protected]Correspondence[email protected]
 show all
Pages 4363-4369 | Published online: 10 Oct 2018

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ganlu Ouyang, Xibiao Yang, Xiangbing Deng, Wenjian Meng, Yongyang Yu, Bing Wu, Dan Jiang, Pei Shu, Ziqiang Wang, Jin Yao & Xin Wang. (2021) Predicting Response to Total Neoadjuvant Treatment (TNT) in Locally Advanced Rectal Cancer Based on Multiparametric Magnetic Resonance Imaging: A Retrospective Study. Cancer Management and Research 13, pages 5657-5669.
Read now

Articles from other publishers (8)

Maria Chiara Lo Greco, Madalina La Rocca, Giorgia Marano, Irene Finocchiaro, Rocco Luca Emanuele Liardo, Roberto Milazzotto, Grazia Acquaviva, Antonello Basile, Stefano Palmucci, Pietro Valerio Foti, Stefano Pergolizzi, Antonio Pontoriero, Silvana Parisi & Corrado Spatola. (2023) Integrated Intensified Chemoradiation in the Setting of Total Neoadjuvant Therapy (TNT) in Patients with Locally Advanced Rectal Cancer: A Retrospective Single-Arm Study on Feasibility and Efficacy. Cancers 15:3, pages 921.
Crossref
Mian Chen, Jianwei Zhang, Yujie Hou, Huashan Liu, Xinjuan Fan, Shuangling Luo, Zhanzhen Liu, Huanxin Hu, Sicong Lai, Liang Kang & Liang Huang. (2023) Clinical significance of adjuvant chemotherapy for pathological complete response rectal cancer patients with acellular mucin pools after neoadjuvant chemoradiotherapy. Therapeutic Advances in Gastroenterology 16, pages 175628482211178.
Crossref
Lili Shen, Chao Li, Jingwen Wang, Jin Fan & Ji Zhu. (2022) CEA levels predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer*. Oncology and Translational Medicine 8:4, pages 180-185.
Crossref
Likun Wang, Xueliang Wu, Wengui Xu, Lei Gao, Ximo Wang & Tian Li. (2022) Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer. Frontiers in Oncology 12.
Crossref
Yan Yuan, Wei-Wei Xiao, Wei-Hao Xie, Pei-Qiang Cai, Qiao-Xuan Wang, Hui Chang, Bao-Qing Chen, Wen-Hao Zhou, Zhi-Fan Zeng, Xiao-Jun Wu, Qing Liu, Li-Ren Li, Rong Zhang & Yuan-Hong Gao. (2021) Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection. BMC Cancer 21:1.
Crossref
A. A. Aniskin, D. V. Kuzmichev, Z. Z. Mamedli & A. V. Polynovskiy. (2021) Three-year outcomes of sandwich therapy in patients with locally advanced cancer of the middle and lower rectum. Pelvic Surgery and Oncology 11:2, pages 29-35.
Crossref
Zizhong Xu, Yating Hu & Zhaohui Yu. (2021) Effect of the ACY‑1 gene on HER2 and TRAIL expression in rectal carcinoma. Experimental and Therapeutic Medicine 22:2.
Crossref
Xiaofeng Tang, Wu Jiang, Haojiang Li, Fei Xie, Annan Dong, Lizhi Liu & Li Li. (2020) Predicting poor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: Model constructed using pre-treatment MRI features of structured report template. Radiotherapy and Oncology 148, pages 97-106.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.